| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| Lining Cao, Rui Hu, Ting Xu, Zhen-Ning Zhang, Weida Li, Jianfeng L. Characterization of Induced Pluripotent Stem Cell-derived Human Serotonergic Neurons. Frontiers in cellular neuroscience. vol 11. 2020-09-30. PMID:28533745. |
in the brain, the serotonergic neurons located in the raphe nucleus are the unique resource of the neurotransmitter serotonin, which plays a pivotal role in the regulation of brain development and functions. |
2020-09-30 |
2023-08-13 |
human |
| Kazushige Mizoguchi, Yasushi Ikarash. Cellular Pharmacological Effects of the Traditional Japanese Kampo Medicine Yokukansan on Brain Cells. Frontiers in pharmacology. vol 8. 2020-09-30. PMID:28979206. |
regarding the pharmacological mechanisms underlying its efficacy, we recently reviewed the multiple effects of yks on the neurotransmitter systems (e.g., glutamatergic, serotonergic, dopaminergic, cholinergic, gabaergic, and adrenergic neurotransmission) in various brain regions that are related to the psychological, emotional, cognitive, or memory functions. |
2020-09-30 |
2023-08-13 |
Not clear |
| Cristy Phillips, Atoossa Fahim. Immune and Neuroprotective Effects of Physical Activity on the Brain in Depression. Frontiers in neuroscience. vol 12. 2020-09-30. PMID:30093853. |
physical activity optimizes the stress response, neurotransmitter level and function (e.g., serotonergic, noradrenergic, dopaminergic, and glutamatergic), myokine production (e.g., interleukin-6), transcription factor levels and correlates [e.g., peroxisome proliferator-activated receptor c coactivator-1α [pgc-1α], mitochondrial density, nitric oxide pathway activity, ca |
2020-09-30 |
2023-08-13 |
Not clear |
| Raphael J. Leo, Robert L. Barki. Antidepressant Use in Chronic Pain Management: Is There Evidence of a Role for Duloxetine? Primary care companion to the Journal of clinical psychiatry. vol 5. issue 3. 2020-09-29. PMID:15154022. |
it exerts simultaneous noradrenergic and serotonergic neurotransmitter effects. |
2020-09-29 |
2023-08-12 |
Not clear |
| Sudip Dhakal, Ian Macreadi. Tyramine and Amyloid Beta 42: A Toxic Synergy. Biomedicines. vol 8. issue 6. 2020-09-28. PMID:32486277. |
implicated in various diseases including parkinson's disease, huntington's disease, migraines, schizophrenia and increased blood pressure, tyramine plays a crucial role as a neurotransmitter in the synaptic cleft by reducing serotonergic and dopaminergic signaling through a trace amine-associated receptor (taar1). |
2020-09-28 |
2023-08-13 |
Not clear |
| Ana Muñoz, Andrea Lopez-Lopez, Carmen M Labandeira, Jose L Labandeira-Garci. Interactions Between the Serotonergic and Other Neurotransmitter Systems in the Basal Ganglia: Role in Parkinson's Disease and Adverse Effects of L-DOPA. Frontiers in neuroanatomy. vol 14. 2020-09-28. PMID:32581728. |
interactions between the serotonergic and other neurotransmitter systems in the basal ganglia: role in parkinson's disease and adverse effects of l-dopa. |
2020-09-28 |
2023-08-13 |
Not clear |
| O Yu Fedorenko, S A Ivanov. [A new look at the genetics of neurocognitive deficits in schizophrenia]. Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova. vol 120. issue 8. 2020-09-16. PMID:32929943. |
the article presents current literature data on genetic studies of neurocognitive deficit in schizophrenia, including the genes of neurotransmitter systems (dopaminergic, glutamatergic, and serotonergic); genes analyzed in genome-wide association studies (gwas), as well as other genetic factors related to the pathophysiological mechanisms underlying schizophrenia and neurocognitive disorders. |
2020-09-16 |
2023-08-13 |
Not clear |
| Jesús M López, Ruth Morona, Agustín Gonzále. Pattern of nitrergic cells and fibers organization in the central nervous system of the Australian lungfish, Neoceratodus forsteri (Sarcopterygii: Dipnoi). The Journal of comparative neurology. vol 527. issue 11. 2020-09-14. PMID:30689201. |
combined immunohistochemistry was used for simultaneous detection of nos with catecholaminergic, cholinergic, and serotonergic structures, aiming to establish accurately the localization of the nitrergic elements and to assess possible interactions between these neurotransmitter systems. |
2020-09-14 |
2023-08-13 |
Not clear |
| Rong Yang, Meng-Qi Zhang, Ying Xue, Rui Yang, Mi-Mi Tan. Dietary of n-3 polyunsaturated fatty acids influence neurotransmitter systems of rats exposed to unpredictable chronic mild stress. Behavioural brain research. vol 376. 2020-09-03. PMID:31445977. |
high-performance liquid chromatography coupled to tandem mass spectrometry (hplc-ms/ms) was used to quantify the levels of neurotransmitters and their metabolites involved in serotonergic, dopaminergic, noradrenergic, gabaergic neurotransmitter systems in hippocampus and prefrontal cortex. |
2020-09-03 |
2023-08-13 |
rat |
| Gabriela Pandini Silote, Ariandra Sartim, Amanda Sales, Amanda Eskelund, F S Guimarães, Gregers Wegener, Samia Joc. Emerging evidence for the antidepressant effect of cannabidiol and the underlying molecular mechanisms. Journal of chemical neuroanatomy. vol 98. 2020-08-17. PMID:31039391. |
cbd has a complex pharmacology, with the ability to interact with multiple neurotransmitter systems involved in depression, including the serotonergic, glutamatergic, and endocannabinoid systems. |
2020-08-17 |
2023-08-13 |
Not clear |
| L Holper, D Ben-Shachar, J J Man. Psychotropic and neurological medication effects on mitochondrial complex I and IV in rodent models. European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology. vol 29. issue 9. 2020-08-07. PMID:31320210. |
potential contributions to the drug effects were found to be related to the drugs' neurotransmitter receptor profiles with adrenergic (α1b), dopaminergic (d1/2), glutaminergic (nmda1,3), histaminergic (h1), muscarinic (m1,3), opioid (op1-3), serotonergic (5-ht |
2020-08-07 |
2023-08-13 |
Not clear |
| Eliseu da Cruz Moreira-Junio. Hyper-serotonergic state determines onset and progression of idiopathic Parkinson's disease. Medical hypotheses. vol 133. 2020-07-07. PMID:31542611. |
the strong serotonergic connection between the raphe nuclei and the dorsal raphe nuclei with the basal ganglia, all important brain structures associated with the pathophysiology of pd, emphasize a potential role for this neurotransmitter in pd. |
2020-07-07 |
2023-08-13 |
Not clear |
| Mark A Oyama, Chad Elliott, Kerry A Loughran, Alexander P Kossar, Estibaliz Castillero, Robert J Levy, Giovanni Ferrar. Comparative pathology of human and canine myxomatous mitral valve degeneration: 5HT and TGF-β mechanisms. Cardiovascular pathology : the official journal of the Society for Cardiovascular Pathology. vol 46. 2020-06-22. PMID:32006823. |
one such mechanism involves the neurotransmitter serotonin (5ht), which has been linked to development of valvulopathy in a variety of settings, including valvulopathy induced by serotonergic drugs, serotonin-producing carcinoid tumors, and development of valvulopathy in laboratory animals exposed to high levels of serotonin. |
2020-06-22 |
2023-08-13 |
human |
| Manuel E Jimenez, Nancy E Reichman, Colter Mitchell, Lisa Schneper, Sara McLanahan, Daniel A Notterma. Shared Reading at Age 1 Year and Later Vocabulary: A Gene-Environment Study. The Journal of pediatrics. vol 216. 2020-06-19. PMID:31402141. |
to assess the extent to which associations between shared reading at age 1 years and child vocabulary at age 3 years differ based on the presence of sensitizing alleles in the dopaminergic and serotonergic neurotransmitter systems. |
2020-06-19 |
2023-08-13 |
Not clear |
| Urjita H Shah, Javier González-Maes. Serotonin and Glutamate Interactions in Preclinical Schizophrenia Models. ACS chemical neuroscience. vol 10. issue 7. 2020-06-11. PMID:30807107. |
the serotonergic and glutamatergic neurotransmitter systems have both been implicated in the pathophysiology of schizophrenia, and there are multiple lines of evidence to demonstrate that they can interact in a functionally relevant manner. |
2020-06-11 |
2023-08-13 |
Not clear |
| Heather Wilson, George Dervenoulas, Gennaro Pagano, Christos Koros, Tayyabah Yousaf, Marina Picillo, Sotirios Polychronis, Athina Simitsi, Beniamino Giordano, Zachary Chappell, Benjamin Corcoran, Maria Stamelou, Roger N Gunn, Maria Teresa Pellecchia, Eugenii A Rabiner, Paolo Barone, Leonidas Stefanis, Marios Politi. Serotonergic pathology and disease burden in the premotor and motor phase of A53T α-synuclein parkinsonism: a cross-sectional study. The Lancet. Neurology. vol 18. issue 8. 2020-06-08. PMID:31229470. |
given the known neurochemical changes in the serotonergic system and their association with symptoms of parkinson's disease, we hypothesised that carriers of the a53t snca mutation might show abnormalities in the serotonergic neurotransmitter system before the diagnosis of parkinson's disease, and that this pathology might be associated with measures of parkinson's burden. |
2020-06-08 |
2023-08-13 |
Not clear |
| Florence Evelyne Perrin, Harun Najib Noristan. Serotonergic mechanisms in spinal cord injury. Experimental neurology. vol 318. 2020-03-02. PMID:31085200. |
we then present a comprehensive overview of changes in serotonergic axons after cns damage, and discuss their plasticity upon altered 5-ht neurotransmitter levels. |
2020-03-02 |
2023-08-13 |
Not clear |
| Bernadet L Klaassens, Joop M A van Gerven, Erica S Klaassen, Jeroen van der Grond, Serge A R B Rombout. Cholinergic and serotonergic modulation of resting state functional brain connectivity in Alzheimer's disease. NeuroImage. vol 199. 2020-02-26. PMID:31112788. |
disruption of cholinergic and serotonergic neurotransmitter systems is associated with cognitive, emotional and behavioural symptoms of alzheimer's disease (ad). |
2020-02-26 |
2023-08-13 |
human |
| Geoffrey A Dunn, Joel T Nigg, Elinor L Sulliva. Neuroinflammation as a risk factor for attention deficit hyperactivity disorder. Pharmacology, biochemistry, and behavior. vol 182. 2020-02-25. PMID:31103523. |
alterations in neurotransmitter systems, including the dopaminergic, serotonergic and glutamatergic systems, are observed in adhd populations. |
2020-02-25 |
2023-08-13 |
human |
| Sakshi, Bikash Chandra Swain, Anand Kant Das, Umakanta Tripath. Probing third-order nonlinearity in serotonin: A Z-scan study. Spectrochimica acta. Part A, Molecular and biomolecular spectroscopy. vol 223. 2020-02-11. PMID:31280124. |
our robust and straightforward strategy to probe the monoamine neurotransmitter properties will provide new avenues to investigate serotonergic processes. |
2020-02-11 |
2023-08-13 |
Not clear |